NCT01921803View on ClinicalTrials.gov

Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

July 14, 2020

Study Completion Date

July 14, 2020

Conditions
Prostate Cancer
Interventions
RADIATION

hypofractionation

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT01921803 - Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter